ILCN Editor Dr. Corey J. Langer reflects on highlights from the past year and looks at the year to come. Read more
Updated Guidelines Provide Vital Insights for Pain Management of Cancer Patients
Nick IppolitoIn part 2 of our series on palliative care, expert Dr. Yoshihisa Matsumoto explains why general guides cannot replace therapeutic planning based on careful assessment of an individual patient’s pain. Read more
Passing of The Baton—On the Death of Patient Research Advocates
Angus Pratt, MBAPatient Perspective: We honor those we’ve lost by continuing their advocacy work, patient advocate Angus Pratt says. Read more
IASLC names J. Michael Hoehn COO. FDA approves adagrasib for KRAS G12C-mutated NSCLC. NHS England increases access to screening in effort to catch cancers earlier. Read more
Guideline-Concordant Surgery, Adjuvant Therapy, and the Promise of Curative-Intent Lung Cancer Surgery: What Are We Up Against?
Osa Ogbeide, MD+more
In a “tale of two trials,” Drs. Ogbeide and Osarogiagbon use insights from the ALCHEMIST trial population to try to understand outcomes disparities between North America and Japan. Read more
New Screening Approach Needed to Detect Lung Cancer in Patients who Never Smoked
Erin JungmeyerDuring ACLC 2022, Dr. Gee-Chen Chang made the case for moving beyond smoking history to identify at-risk patients and shared an alternative risk predication model that compared favorably against NLST and NELSON. Read more
Palliative Care Benefits Vary Depending on Providers, Timing
Erin JungmeyerIn the first of a series of articles on supportive care in lung cancer, Dr. David Hui outlines the needs and reviews evidence-based best practices. Read more
Learn how new guidance from the UK’s National Institutes for Health Care Excellence addresses an unmet clinical need for patients with EGFR+ NSCLC with exon 20 insertion and stay up to date on the latest meeting news from IASLC. Read more